31 results
6-K
LEGN
Legend Biotech Corp
20 Nov 23
Legend Biotech Reports Third Quarter 2023 Results and Recent Highlights
6:02am
our pro-rata share of collaboration net trade sales for which Janssen Biotech, Inc. (“Janssen”) is the principal in the sale to the customer under
6-K
LEGN
Legend Biotech Corp
15 Aug 23
Legend Biotech Reports Second Quarter 2023 Results and Recent Highlights
6:10am
in the sale to the customer under the collaboration and license agreement with Janssen (the “Janssen Agreement”). Other revenue is related to an exclusive
6-K
EX-99.1
qj72ybbddr
14 Apr 23
Master Technology Transfer, Manufacturing and Clinical Supply Services Agreement for Bcma Car-t Product
8:30am
6-K
EX-99.1
fxue64
3 Apr 23
Legend Biotech 6-K
4:01pm
6-K
EX-10.1
37ui3s8 vlgqnnk
3 Oct 22
Legend Biotech Corporation 6-K
4:02pm
6-K
EX-10.1
vx257cp
4 Aug 22
Legend Biotech Appoints Three New Directors and Elects New Chairman of the Board
4:18pm
424B5
wxwy5l
27 Jul 22
Prospectus supplement for primary offering
4:32pm
424B5
2bouzj
25 Jul 22
Prospectus supplement for primary offering
4:29pm
6-K
EX-99.2
mc5fh d9hv7tei9xu
25 Jul 22
Legend Biotech Corporation Announces Proposed Public Offering
4:07pm
6-K
EX-99.3
dmqzc8rbneissu87ohd9
25 Jul 22
Legend Biotech Corporation Announces Proposed Public Offering
4:07pm
6-K
EX-99.2
s0lk2v
14 Dec 21
Legend Biotech Corporation Announces Proposed Public Offering
4:27pm
6-K
EX-99.3
24wamkymgo8ys2ubs
14 Dec 21
Legend Biotech Corporation Announces Proposed Public Offering
4:27pm
6-K
EX-99.1
lycfiu572b4dd9fhp8j7
16 Nov 21
Legend Biotech Corp. 6-K
8:30am
6-K
2mz1q
23 Aug 21
Current report (foreign)
8:16am
6-K
EX-99.1
09wrz84m zynr
23 Aug 21
Legend Biotech Corporation 6-K
8:00am